<p>4*10<sup>6</sup> CD8 OT-I T cells were transferred into TF-OVAxDEREG mice at day 0 and day 21 (A–C). In addition, Treg were depleted by application of DT, either at the time point of the first transfer of CD8 OT-I T cells (B) or at the time point of the second CD8 OT-I T-cell transfer (C). Control mice received DT alone at both time points (D). Depicted are serum ALT levels of mice at the indicated time points. Statistics were performed using the Wilcoxon-signed-rank-test; p-values<0.05 were considered significant. (A-D) Histology of livers was assessed at day 26 using H&E staining (magnification 100x), as well as antibodies against CD3 (magnification 200x; red membrane staining). Depicted are representative pictures from TF-OVAxDEREG mi...
<p>Purified CD8<sup>+</sup> T cells from wt OT–I and CXCR6<sup>GFP/GFP</sup> OT–I mice were mixed in...
<p>(A) To determine how early CD8<sup>+</sup> T cells are activated in the liver, 4×10<sup>6</sup> T...
<p>Isotype, CD4 and/or CD8 mAbs (100 µg per mouse) was administrated i.p. to Balb/c mice (n = 8 per ...
<p>4x10<sup>6</sup> OT-I CD8 T cells were transferred intravenously into TF-OVAxDEREG mice and treat...
<p>4x10<sup>6</sup> CD8 OT-I T cells were transferred intravenously into TF-OVA mice. Non-parenchyma...
and whether hepatic regulatory T cells are functional in patients with autoimmune hepatitis... Depl...
<p>(A) CFSE-labeled CD8 OT-I T cells were stimulated by APCs isolated from spleens of TF-OVA mice fo...
The role of regulatory CD4 T cells (Treg) in immune-mediated liver disease is still under debate. It...
<p>Adoptive transfer of OT-I CD8+ cells to the OVA_X_CreER<sup>T2</sup> mice either pre-treated with...
<p>(A) Four million naïve (open squares) or effector (open circles) OT-II T-cells were transferred a...
The liver has the ability to prime immune responses against neo antigens provided upon infections. H...
The liver has the ability to prime immune responses against neo antigens provided upon infections. H...
<div><p>The liver has the ability to prime immune responses against neo antigens provided upon infec...
CD8 T cells kill their targets in an antigen-specific manner by delivering lethal granzymes to targe...
<p>(A) Eight million OT-I T-cells were transferred intravenously into TF-OVA mice (+ Hepatitis), or ...
<p>Purified CD8<sup>+</sup> T cells from wt OT–I and CXCR6<sup>GFP/GFP</sup> OT–I mice were mixed in...
<p>(A) To determine how early CD8<sup>+</sup> T cells are activated in the liver, 4×10<sup>6</sup> T...
<p>Isotype, CD4 and/or CD8 mAbs (100 µg per mouse) was administrated i.p. to Balb/c mice (n = 8 per ...
<p>4x10<sup>6</sup> OT-I CD8 T cells were transferred intravenously into TF-OVAxDEREG mice and treat...
<p>4x10<sup>6</sup> CD8 OT-I T cells were transferred intravenously into TF-OVA mice. Non-parenchyma...
and whether hepatic regulatory T cells are functional in patients with autoimmune hepatitis... Depl...
<p>(A) CFSE-labeled CD8 OT-I T cells were stimulated by APCs isolated from spleens of TF-OVA mice fo...
The role of regulatory CD4 T cells (Treg) in immune-mediated liver disease is still under debate. It...
<p>Adoptive transfer of OT-I CD8+ cells to the OVA_X_CreER<sup>T2</sup> mice either pre-treated with...
<p>(A) Four million naïve (open squares) or effector (open circles) OT-II T-cells were transferred a...
The liver has the ability to prime immune responses against neo antigens provided upon infections. H...
The liver has the ability to prime immune responses against neo antigens provided upon infections. H...
<div><p>The liver has the ability to prime immune responses against neo antigens provided upon infec...
CD8 T cells kill their targets in an antigen-specific manner by delivering lethal granzymes to targe...
<p>(A) Eight million OT-I T-cells were transferred intravenously into TF-OVA mice (+ Hepatitis), or ...
<p>Purified CD8<sup>+</sup> T cells from wt OT–I and CXCR6<sup>GFP/GFP</sup> OT–I mice were mixed in...
<p>(A) To determine how early CD8<sup>+</sup> T cells are activated in the liver, 4×10<sup>6</sup> T...
<p>Isotype, CD4 and/or CD8 mAbs (100 µg per mouse) was administrated i.p. to Balb/c mice (n = 8 per ...